Scholars Central

Conference abstractPublished 27 Oct 2015

The potential effect of Caffeine and Nicotine co-administration on the induction of Alzheimers disease

Authors: Azza A Ali, Hebatalla I Ahmed, Hanan A Abd El-Samee, Ebtehal El-Demerdash

Al-Azhar University, Egypt Ain Shams University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimers disease (AD) is a progressive neurodegenerative disease characterized clinically by memory impairment and other cognitive problems. Caffeine and nicotine are the most commonly co-used psychostimulants. Caffeine is one of the major contributors to the dietary antioxidants which prevent oxidative damage and may reduce the risk of chronic neurodegenerative diseases. Nicotine has the ability to decrease level of ROS in the hippocampus and suggested to attenuate the impairment of memory associated with AD. The purpose of the study was to evaluate the influence of caffeine and nicotine co-administration against aluminium-induced AD in rats. Five groups of rats were used and received daily for five weeks: Saline for control group, ALCl3 (70mg/kg, IP) for AD group, while treated groups received together with ALCl3, either Caffeine (5mg/kg, IP), Nicotine (1mg/kg, SC) or both Caffeine and Nicotine. Three behavioral experiments were performed: Forced swimming test, Morris water maze task and Conditioned-avoidance and learning test. Histopathological changes in the brain and biochemical changes in Acetyl cholinesterase (ACHE) as well as oxidative parameters; (MDA, SOD, TAC) were also evaluated for all groups. Results of the behavioral tests showed that caffeine and nicotine co-administration had more pronounced protecting effect from learning and memory impairment induced by ALCL3 than each one alone. They significantly increased both swimming and climbing score as well as time spent in the correct quadrant, while significantly decrease number of learning trials. Caffeine and nicotine co-administration also prevent neuronal degeneration in the hippocampus and the eosinophilic plagues in the striatum induced by ALCL3 while nicotine alone still showed mild gliosis in striatum. The marked protection of caffeine and nicotine co-administration confirmed also by the significant increase in TAC and SOD and decrease in MDA and ACHE in brain tissue. In conclusion, co-administration of caffeine and nicotine can reduce the risk of neuronal degeneration in the hippocampus and attenuate the impairment of learning and memory associated with AD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Azza A Ali”
  • BylineArticles whose byline prints “Hebatalla I Ahmed”
  • BylineArticles whose byline prints “Hanan A Abd El-Samee”
  • BylineArticles whose byline prints “Ebtehal El-Demerdash”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels